PSYENCE BIOMEDICAL LTD Restricted Cash And Cash Equivalents
PSYENCE BIOMEDICAL LTD (PBM) had Restricted Cash And Cash Equivalents of $7.20 million as of 2025-09-30, per its 6-K filed 2025-11-20.
Financial Statements › Notes
ifrs-full:RestrictedCashAndCashEquivalents · last filed 2025-11-20
- 2025-09-30: Restricted Cash And Cash Equivalents $7.20M.
- 2025-03-31: Restricted Cash And Cash Equivalents $6.17M.
- 2024-03-31: Restricted Cash And Cash Equivalents $762.80K.
| Period end | Restricted Cash And Cash Equivalents |
|---|---|
| 2025-09-30 | $7.20M 6-K · filed 2025-11-20 |
| 2025-03-31 | $6.17M 6-K · filed 2025-11-20 |
| 2024-03-31 | $762.80K 20-F · filed 2025-06-25 |